-
Je něco špatně v tomto záznamu ?
The legal framework for European cervical cancer screening programmes
O. Májek, A. Anttila, M. Arbyn, EB. van Veen, B. Engesæter, S. Lönnberg,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Free Medical Journals
od 1996 do Před 1 rokem
PubMed Central
od 2008
Open Access Digital Library
od 1996-01-01
CINAHL Plus with Full Text (EBSCOhost)
od 2006-01-02
Oxford Journals Open Access Collection
od 1991-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1991
PubMed
30265313
DOI
10.1093/eurpub/cky200
Knihovny.cz E-zdroje
- MeSH
- časná detekce nádoru metody normy MeSH
- důvěrnost informací zákonodárství a právo MeSH
- lidé MeSH
- nádory děložního čípku diagnóza MeSH
- registrace normy MeSH
- vytváření politiky MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Evropa MeSH
BACKGROUND: A comprehensive legal framework needs to be developed to run the health services and to regulate the information systems required to manage and to ensure the quality of cancer screening programmes. The aim of our study was to document and to compare the status of legal basis for cervical screening registration in European countries. METHODS: An electronic questionnaire including questions on governance, decision-making structures and legal framework was developed. The primary responses were collected by September 2016. RESULTS: We sent the questionnaire to representatives of 35 European countries (28 countries of the EU, with the United Kingdom included as 4 countries; 4 EFTA member countries: Iceland, Liechtenstein, Norway, and Switzerland); responses were collected from 33 countries. The legal framework makes it possible to personally invite individuals in 29 countries (88%). Systematic screening registration in an electronic registry is legally enshrined in 23 countries (70%). Individual linkage of records between screening and cancer registries is allowed in 19 of those countries. Linkage studies involving cancer and screening registries have been conducted in 15 countries. CONCLUSION: Although the majority of EU/EFTA countries have implemented population-based screening, only half of them have successfully performed record linkage studies, which are nevertheless a key recommendation for quality assurance of the entire screening process. The European legislation is open to the possibility of using health data for these purposes; however, member states themselves must recognize the public interest to create a legal basis, which would enable all the necessary functions for high-quality cancer screening programmes.
Finnish Cancer Registry Helsinki Finland
MedLawconsult Den Haag The Netherlands
The Norwegain cervical cancer screening programme Cancer Registry of Norway Oslo Norway
Unit of Cancer Epidemiology Belgian Cancer Centre Sciensano Brussels Belgium
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19034989
- 003
- CZ-PrNML
- 005
- 20191011105942.0
- 007
- ta
- 008
- 191007s2019 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/eurpub/cky200 $2 doi
- 035 __
- $a (PubMed)30265313
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Májek, Ondřej $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Institute of Health Information and Statistics, Praha 2, Czech Republic.
- 245 14
- $a The legal framework for European cervical cancer screening programmes / $c O. Májek, A. Anttila, M. Arbyn, EB. van Veen, B. Engesæter, S. Lönnberg,
- 520 9_
- $a BACKGROUND: A comprehensive legal framework needs to be developed to run the health services and to regulate the information systems required to manage and to ensure the quality of cancer screening programmes. The aim of our study was to document and to compare the status of legal basis for cervical screening registration in European countries. METHODS: An electronic questionnaire including questions on governance, decision-making structures and legal framework was developed. The primary responses were collected by September 2016. RESULTS: We sent the questionnaire to representatives of 35 European countries (28 countries of the EU, with the United Kingdom included as 4 countries; 4 EFTA member countries: Iceland, Liechtenstein, Norway, and Switzerland); responses were collected from 33 countries. The legal framework makes it possible to personally invite individuals in 29 countries (88%). Systematic screening registration in an electronic registry is legally enshrined in 23 countries (70%). Individual linkage of records between screening and cancer registries is allowed in 19 of those countries. Linkage studies involving cancer and screening registries have been conducted in 15 countries. CONCLUSION: Although the majority of EU/EFTA countries have implemented population-based screening, only half of them have successfully performed record linkage studies, which are nevertheless a key recommendation for quality assurance of the entire screening process. The European legislation is open to the possibility of using health data for these purposes; however, member states themselves must recognize the public interest to create a legal basis, which would enable all the necessary functions for high-quality cancer screening programmes.
- 650 _2
- $a důvěrnost informací $x zákonodárství a právo $7 D003219
- 650 _2
- $a časná detekce nádoru $x metody $x normy $7 D055088
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a vytváření politiky $7 D011050
- 650 _2
- $a registrace $x normy $7 D012042
- 650 _2
- $a nádory děložního čípku $x diagnóza $7 D002583
- 651 _2
- $a Evropa $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Anttila, Ahti $u Finnish Cancer Registry, Helsinki, Finland.
- 700 1_
- $a Arbyn, Marc $u Unit of Cancer Epidemiology, Belgian Cancer Centre, Sciensano, Brussels, Belgium.
- 700 1_
- $a van Veen, Evert-Ben $u MedLawconsult, Den Haag, The Netherlands.
- 700 1_
- $a Engesæter, Birgit $u The Norwegain cervical cancer screening programme, Cancer Registry of Norway, Oslo, Norway.
- 700 1_
- $a Lönnberg, Stefan $u Finnish Cancer Registry, Helsinki, Finland.
- 773 0_
- $w MED00012099 $t European journal of public health $x 1464-360X $g Roč. 29, č. 2 (2019), s. 345-350
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30265313 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20191011110402 $b ABA008
- 999 __
- $a ok $b bmc $g 1451649 $s 1073539
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 29 $c 2 $d 345-350 $e 20190401 $i 1464-360X $m European journal of public health $n Eur J Public Health $x MED00012099
- LZP __
- $a Pubmed-20191007